Last reviewed · How we verify

NCT04909320

Mobile-based Positive Psychological Support for Smoking Cessation Via "Quit to Win" Contest 2021 (QTW 2021)

Status unknown NA Last updated 17 August 2022
What this trial tests

NA trial testing AWARD advice in Smoking Cessation in 1,094 participants. Status unknown.

Timeline
12 June 2021
Primary endpoint
30 June 2022
30 June 2023

Quick facts

Lead sponsorThe University of Hong Kong
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment1,094
Start date12 June 2021
Primary completion30 June 2022
Estimated completion30 June 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

18 and older, any sex, with Smoking Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to explore the effectiveness of a combined intervention using brief cessation advice and personalized chat-based positive psychological support compared with the control group on current smokers who join the Quit to Win Contest.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Behavioral Support by Ex-Smoking Peers Using Instant Messaging for Smoking Cessation: A Randomized Controlled Trial.
    Guo Z, Luk TT, Weng X, Wu Y, et al · · 2026 · PMID 40939935 · DOI 10.1016/j.chest.2025.07.4110

Verify or expand the search:

Other trials of AWARD advice

Trials testing the same drug.

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04909320.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing